For comparison, sulfasalazine (50 mg/kg intraperitoneally, once daily) (moderately effective) or 6--methylprednisolone (1.0 mg/kg intraperitoneally, once daily) (aggravation) was given
Anyone with active or prior cancer, or strong family history, should not use IGF-1 LR3
Packaging and labeling dont always make the distinction obvious to a casual reader, and the terms get used loosely in conversation, online forums, and even some product listings
It could pursue formal rulemaking, announce an interim enforcement position, request more information, narrow conditions, or take another approach within its authority
However, it should be noted that the trials were conducted in the same centers across the same time frame